当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析 - 现金流量表

安图生物

(603658)

  

流通市值:191.43亿  总市值:191.43亿
流通股本:5.71亿   总股本:5.71亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,189,097,872.314,702,576,301.333,420,516,955.892,198,247,562.32
  收到的税费返还773,234.8621,408,259.9815,518,648.518,453,225.55
  收到其他与经营活动有关的现金40,724,021.7195,252,223.18145,726,926.86113,353,151.96
  经营活动现金流入小计1,230,595,128.874,919,236,784.493,581,762,531.262,320,053,939.83
  购买商品、接受劳务支付的现金363,392,484.111,467,448,287.221,076,737,751.87727,322,634.79
  支付给职工以及为职工支付的现金475,721,428.361,159,015,933.18916,538,119.4673,170,786.68
  支付的各项税费126,410,106.27487,966,552.96375,636,923.81262,991,988.17
  支付其他与经营活动有关的现金118,498,609.63463,124,248.38367,427,922.79246,384,604.84
  经营活动现金流出小计1,084,022,628.373,577,555,021.742,736,340,717.871,909,870,014.48
  经营活动产生的现金流量净额146,572,500.51,341,681,762.75845,421,813.39410,183,925.35
二、投资活动产生的现金流量:
  收回投资收到的现金3,450,961.66---
  取得投资收益收到的现金2,235,870894,348894,348894,348
  处置固定资产、无形资产和其他长期资产收回的现金净额-109,282.3109,282.310,082.3
  收到的其他与投资活动有关的现金2,222,136,910.874,979,269,563.554,039,062,461.622,767,068,985.84
  投资活动现金流入小计2,227,823,742.534,980,273,193.854,040,066,091.922,767,973,416.14
  购建固定资产、无形资产和其他长期资产支付的现金133,159,505.15604,302,271.16464,971,414.97326,499,808.64
  投资支付的现金88,499,49417,500,0007,500,0007,500,000
  支付其他与投资活动有关的现金1,836,927,142.314,773,821,435.963,329,162,589.432,131,839,077.53
  投资活动现金流出小计2,058,586,141.465,395,623,707.123,801,634,004.42,465,838,886.17
  投资活动产生的现金流量净额169,237,601.07-415,350,513.27238,432,087.52302,134,529.97
三、筹资活动产生的现金流量:
  吸收投资收到的现金-14,455,00014,455,00014,455,000
  其中:子公司吸收少数股东投资收到的现金-14,455,00014,455,00014,455,000
  取得借款收到的现金3,000,000364,670,786.89361,670,786.89361,670,786.89
  收到其他与筹资活动有关的现金160,850,0001,639,509,118.121,206,334,001.7919,397,210.85
  筹资活动现金流入小计163,850,0002,018,634,905.011,582,459,788.591,295,522,997.74
  偿还债务支付的现金-852,670,786.89852,670,786.89779,970,786.89
  分配股利、利润或偿付利息支付的现金283,730.83728,785,691.1728,357,690.12727,179,676.69
  其中:子公司支付给少数股东的股利、利润-2,102,1002,102,1002,102,100
  支付其他与筹资活动有关的现金265,573,745.221,233,471,317.45947,974,071.45501,655,814.9
  筹资活动现金流出小计265,857,476.052,814,927,795.442,529,002,548.462,008,806,278.48
  筹资活动产生的现金流量净额-102,007,476.05-796,292,890.43-946,542,759.87-713,283,280.74
四、汇率变动对现金及现金等价物的影响-7,662,969.99774,015.752,418,501.373,246,257.44
五、现金及现金等价物净增加额206,139,655.53130,812,374.8139,729,642.412,281,432.02
  加:期初现金及现金等价物余额582,870,723.61452,058,348.81452,058,348.81452,058,348.81
  期末现金及现金等价物余额789,010,379.14582,870,723.61591,787,991.22454,339,780.83
补充资料:
  净利润-1,086,384,222.05-578,036,989.75
  资产减值准备-19,708,750.29-14,215,837.01
  固定资产和投资性房地产折旧-427,857,927.85-215,464,941.83
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-427,857,927.85-215,464,941.83
  无形资产摊销-28,181,990.29-13,748,734.82
  长期待摊费用摊销-27,694,870.94-12,897,921.42
  处置固定资产、无形资产和其他长期资产的损失--637,786.38--38,609.84
  固定资产报废损失-4,965,505.65-1,562,991.87
  公允价值变动损失-3,495,613.67-54,112.42
  财务费用-15,562,007.36-9,517,542.81
  投资损失--104,506,851.42--67,250,439.05
  递延所得税--51,008,060.49--529,134.49
  其中:递延所得税资产减少--13,546,443.34--20,410,900.74
    递延所得税负债增加--37,461,617.15-19,881,766.25
  存货的减少--284,740,441.26-57,006,242.84
  经营性应收项目的减少-30,432,966.6--215,522,717.17
  经营性应付项目的增加-129,163,358.86--204,841,745.56
  其他--8,262,674.71--7,539,635.35
  现金的期末余额-582,870,723.61-454,339,780.83
  减:现金的期初余额-452,058,348.81-452,058,348.81
  现金及现金等价物的净增加额-130,812,374.8-2,281,432.02
公告日期2026-04-232026-04-232025-10-302025-08-22
审计意见(境内)标准无保留意见
TOP↑